Browsing by Subject
Ara mostrant els elements 1-20 d 29
-
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
(American Society of Clinical Oncology, 2020-12-01) -
Atypical pattern of response in rectal cancer after neoadjuvant pembrolizumab treatment: a case report, literature review, and proposed management model
(AME Publishing Company, 2023-06-30) -
Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case report
(Frontiers Media, 2022-09-14) -
Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy
(Nature Portfolio, 2022-01-27) -
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
(American Society of Clinical Oncology, 2022-09-01) -
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
(Oxford University Press, 2022-12)